Safety of serotonin (5-HT3) receptor antagonists in patients undergoing surgery and chemotherapy: protocol for a systematic review and network meta-analysis

BACKGROUND: Serotonin (5-HT3) receptor antagonists are a class of antiemetic medications often used to prevent nausea and vomiting among patients undergoing chemotherapy, radiotherapy or surgery. However, recent studies suggest that these agents might be associated with increased cardiac harm. To ex...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Tricco, Andrea C, Soobiah, Charlene, Antony, Jesmin, Hemmelgarn, Brenda, Moher, David, Hutton, Brian, Straus, Sharon E
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2013
Teme:
Protocol
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3702491/
https://ncbi.nlm.nih.gov/pubmed/23810058
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/2046-4053-2-46
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items